Today, the subscription period in Genetic Analysis subsequent offering begins
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Mandatory notification of trade
OSLO, NORWAY – 20 November 2023: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have been allocated GEAN shares in connection with the…
Minutes from the Extraordinary General Meeting
Oslo, Norway, November 20, 2023 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held an Extraordinary General Meeting today, November 20th, at 13:00 hours (CET) on the Company’s premises in…
Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam
Genetic Analysis recently participated in xMAP® Connect EMEA, an industry conference November 8-9 in Amsterdam organized by Luminex Corporation – a DiaSorin Company. Here, GA presented the latest news about…
Notice of Extraordinary General Meeting 2023
Notice is hereby served that an extraordinary general meeting in Genetic Analysis AS (the “Company”) will be held on Monday 20 November2023 at 13:00 hours in the Company’s premises in…
Information avseende nyttjandeperiod av teckningsoptioner av serie TO 2 i Genetic Analysis AS
OSLO, NORGE – 3 november, 2023 – Den 8 november 2023 inleds nyttjandeperioden för de teckningsoptioner av serie TO 2 som emitterades i samband med Genetic Analysis AS:s (“GA” eller…
Correction: Updated intended record date for the intended Subsequent Offering announced in press release, November 2, 2023
Correction of press release regarding subsequent offer
Subscriptions received in separate tranche of previously announced directed share issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Board member resigns at his request
OSLO, NORWAY – November 2, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the board member Staffan Strömberg has resigned from the Board of…
